NCT00233051View on ClinicalTrials.gov

Evaluating Genes in Sputum to Measure Drug Response in COPD

NATerminatedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions

Chronic Obstructive Pulmonary Disease (COPD)EmphysemaChronic Bronchitis

Interventions

DRUG

Salmeterol or Salmeterol/Fluticasone

Trial Locations (1)

80206

National Jewish Medical and Research Center, Denver

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

National Jewish Health

OTHER

NCT00233051 - Evaluating Genes in Sputum to Measure Drug Response in COPD | Biotech Hunter | Biotech Hunter